StonvexLoading…
StonvexStonvexStonvexCore line items from AXTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.12B | $5.28B | $5.18B | $4.88B |
Operating Income | $735.00M | $706.00M | $588.00M | $423.00M |
Net Income | $378.00M | $391.00M | $267.00M | $192.00M |
EPS (Diluted) | $1.74 | $1.78 | $1.21 | $0.86 |
Total Assets | $7.60B | $7.25B | $7.27B | $7.06B |
Total Liabilities | $5.21B | $5.29B | $5.50B | $5.56B |
Cash & Equivalents | $657.00M | $593.00M | $700.00M | $645.00M |
Free Cash Flow OCF − CapEx | $453.00M | $436.00M | $437.00M | $143.00M |
Shares Outstanding | 217.00M | 220.40M | 221.90M | 222.30M |